- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07372690
Goal Attainment Scale in Transplantation (GAST)
Using Goal Attainment Scale (GAS) to Increase Active Involvement of Patients and Their Family in the Identification of Functional Objectives During Hospitalization for Hematopoietic Stem Cell Transplantation (HSCT): a Randomized Controlled Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
HSCT is a potentially curative option for many diseases, including haematological malignancies and refractory solid tumours in children and adolescents. Its use in this age group has increased over the last three decades, as have survival rates decades. However, HSCT can cause a significant number of clinical complications and side effects in both the short and long term. Short-term effects include mucositis, fever, nausea and vomiting, while long-term effects include organ toxicity and fatigue. Allogeneic HSCT recipients can indeed develop graft-versus-host disease, which can lead to extensive multiorgan failure, systemic toxicity and mortality. Previous treatments, the severity of the conditioning regimen, the length of isolation and hospitalisation can all severely impair physical, cognitive and psychosocial functions, resulting in a reduction in quality of life (QoL). Recent studies have shown that exercise and rehabilitation are promising tools for decreasing the side effects of HSCT and improving QoL in the paediatric population undergoing HSCT). A systematic meta-analysis review reported that physical exercise is safe, feasible, and effective in preventing the decline in quality of life and physical performance in paediatric patients undergoing HSCT.
It is widely recognized that rehabilitation treatment in developmental age should consider the multiplicity of altered motor, perceptive, cognitive, affective, communicative and relational functions, their mutual interactions, as well as variables such as age and the role of the family, while respecting the individuality of each child. Health care professionals should treat patients with dignity, sensitivity, kindness, and respect for their individual needs and preferences for medical, clinical and rehabilitative care. These principles characterize the Family Centered Care (FCC), an approach based on the active involvement of the patients and their families in the care process. Other studies showed that uptake of an FCC approach in paediatric settings can positively impact children's HRQL. The FCC approach has been recognized as a model of best practice in pediatric rehabilitation, where it can be integrated in the rehabilitation programme by identifying clinically relevant and functional goals for the patients and their caregivers. Moreover, the approach can increase patient's compliance. Goal Attainment Scaling (GAS) has revealed itself as being a powerful tool to establish personalized goals and to objectively quantify the benefits of rehabilitation treatment. The GAS value lies in the possibility of identifying specific concrete objectives for each patient. The tool, which is used in different fields, is widely applied in pediatric rehabilitation. To date, the effects of active involvement of children, adolescents and their families in the definition of functional goals during hospitalization for HSCT have not yet been studied. The use of GAS to identify and achieve personalized, concrete and functional short-term goals during hospitalization could help patients to maintain a more active lifestyle. Consequently, it will reduce sedentary behaviors which are very frequent in this population. The increase in activity levels could significantly contribute to the maintenance of functional abilities that are often reduced during the treatment phase.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Francesco Saglio, PhD Medical Doctor
- Phone Number: +39 0113135449
- Email: francesco.saglio@unito.it
Study Contact Backup
- Name: Francesca Rossi
- Phone Number: +39 0113131643
- Email: francesca.rossi@unito.it
Study Locations
-
-
TO
-
Torino, TO, Italy, 10126
- Recruiting
- A.O.U. Città della Salute e della Scienza - OIRM
-
Contact:
- Francesca Rossi
- Phone Number: +39 0113131643
- Email: francesca.rossi@unito.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age between 6 months - 17 years and 11 months
- diagnosis of oncological or hematological disease undergoing HSCT
- No specific rehabilitation treatment ongoing at the moment of recruitment
- Written informed consent from patient or parents/legal representative, and age-appropriate assent.
Exclusion Criteria:
- Patients that are not able and willing to comply with study visits and procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Exercise programme (EP) and rehabilitation counselling indication (RCI)
Exercise Program EP is carried out five days a week (two days independently with parental support and three days under supervision). Each 30-minute session is supervised by one therapist for all patients. The EP programme includes three types of exercise: muscle-strengthening exercises for the upper and lower extremities, preceded by a 10-minute warm-up; 15 minutes of aerobic exercise; and 5 minutes of stretching. Rehabilitation counselling indications RCI have to be followed daily. RCI consist of some practical advice on how to adopt an active lifestyle during recovery. Some examples are getting up to go to the bathroom or the window to talk to visitors, sitting on a chair for school lessons. |
Participants assigned in this group follow an Exercise Program and Rehabilitation counselling indications. Exercise Program EP is carried out five days a week (two days independently with parental support and three days under supervision). Each 30-minute session is supervised by one therapist for all patients. The EP programme includes three types of exercise: muscle-strengthening exercises for the upper and lower extremities, preceded by a 10-minute warm-up; 15 minutes of aerobic exercise; and 5 minutes of stretching. Rehabilitation counselling indications RCI have to be followed daily. RCI consist of some practical advice on how to adopt an active lifestyle during recovery. Some examples are getting up to go to the bathroom or the window to talk to visitors, sitting on a chair for school lessons. |
|
Experimental: Exercise programme (EP), rehabilitation counselling indication (RCI) and Goal Attaiment Scale (GAS)
Exercise Program EP is carried out five days a week (two days independently with parental support and three days under supervision). Each 30-minute session is supervised by one therapist for all patients. The EP programme includes three types of exercise: muscle-strengthening exercises for the upper and lower extremities, preceded by a 10-minute warm-up; 15 minutes of aerobic exercise; and 5 minutes of stretching. Rehabilitation counselling indications RCI have to be followed daily. RCI consist of some practical advice on how to adopt an active lifestyle during recovery. Some examples are getting up to go to the bathroom or the window to talk to visitors, sitting on a chair for school lessons. GAS During their hospitalisation, children and caregivers in the experimental group define a functional goal together each week with the help of the therapist. This is verified using Goal Attainment Scaling, which identifies specific and significant objectives for the patient and their family. |
This intervention includes an exercise programme (EP) and rehabilitation counselling indication (RCI) during hospitalisation for HSCT. Participants in the experimental group also set their own functional goals using GAS (Goal Attainment Scaling) with the help of the therapist during hospitalization. EP is carried out five days/week (30-minute per session) and it consists in muscle-strengthening, aerobic and stretching exercises. RCI have to be followed daily and they are some practical advice on how to adopt an active lifestyle during recovery. GAS is structured around the definition of a starting level (-1) and the goal to be achieved (level 0). Two higher levels (+1 and +2) are used to indicate better performance than expected, and level -2 is used to indicate regression in the initial functional objective. The "Goaled" app, which is available for free on smartphones and tablets, is used to define and verify the objectives. This should increase patient's motivation. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Abilities Assessment in Paediatric Oncology (FAAPO) Scale
Time Frame: - At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
This tool is a short version of the Gross Motor Function Measure and has been validated for use with Italian paediatric oncology patients aged 6 months to 18 years.
It comprises 36 items, each of which can be scored as 0, 1, 2, 3 or 'not tested'.
The scoring key is as follows: 0 - does not initiate; 1 - initiates; 2 - partially completes; and 3 - completes.
The final FAAP-O score provides a percentage of functional abilities.
|
- At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Global Rating of Change (GCR)
Time Frame: - At hospital discharge - At 60 days after HSCT
|
Change in functional abilities perceived by parents and adolescents between T0 and T1, and between T1 and T2, is tested using Global Rating of Change (GCR).
|
- At hospital discharge - At 60 days after HSCT
|
|
Achievement of the functional objectives established with GAS (Goal Attainment Scaling)
Time Frame: Each 7 days from the baseline to the discharge from the ward.
|
Achievement of the functional objectives established with GAS in the experimental group, using GAS.
|
Each 7 days from the baseline to the discharge from the ward.
|
|
Percentage of adherence to the exercise programme and rehabilitation counselling indications.
Time Frame: Each 7 days from the baseline to the discharge from the ward.
|
Percentage of adherence to the exercise programme and rehabilitation counselling indications.
|
Each 7 days from the baseline to the discharge from the ward.
|
|
Percentage of GAS application in the experimental group.
Time Frame: Each 7 days from the baseline to the discharge from the ward.
|
Percentage of GAS application in the experimental group.
|
Each 7 days from the baseline to the discharge from the ward.
|
|
Sit and Reach Test
Time Frame: - At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
Muscle extensibility of the posterior kinetic chain is measured with Sit and Reach Test.
It is performed by sitting with legs extended against a box, then reaching forward as far as possible over the measuring line, holding for 2 seconds.
It's scored by measuring the distance fingertips reach past (positive) or short of (negative) the toes.
|
- At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
|
Hand grip test
Time Frame: - At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
The Hand Grip Test measures maximum isometric hand and forearm strength using a dynamometer, assessing overall physical capacity and potential indicators of health, functional status, and malnutrition.
The procedure consists in squeezing the device for a few seconds, recording the force (in lbs), and often repeating trials to find the best score.
|
- At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
|
Time Up and Go Test
Time Frame: - At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
The Timed Up and Go (TUG) test is a functional mobility assessment test.
It requires a chair, stopwatch, and tape to mark 3 meters.
A person stands from the chair, walks to the line at a normal pace, turns, walks back, and sits down, with the time recorded from "go" until seated.
|
- At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
|
2-Minutes Walking Test
Time Frame: - At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
The 2-Minute Walk Test (2MWT) assesses a person's walking endurance and aerobic capacity.
It is measured with the maximum distance they can cover in two minutes, walking back and forth along a clear, standardized path (30 metres), at their fastest safe pace.
|
- At the admission to the ward - At hospital discharge - At 60 days after HSCT
|
|
Pediatric Quality of Life Multidimensional Fatigue Scale
Time Frame: - At the admission to the ward - At 60 days after HSCT
|
The Pediatric Quality of Life Multidimensional Fatigue Scale (PedsQL - MFS) is an 18-item questionnaire from the Pediatric Quality of Life Inventory (PedsQL) used to measure fatigue in children and adolescents (ages 2-18), assessing three specific dimensions: General Fatigue, Sleep/Rest Fatigue, and Cognitive Fatigue, with higher scores indicating better quality of life and less fatigue, using a Likert-type scale from "never" to "almost always".
e;
|
- At the admission to the ward - At 60 days after HSCT
|
|
Pediatric Quality of Life Cancer Module
Time Frame: - At the admission to the ward - At 60 days after HSCT
|
The Pediatric Quality of Life Cancer Module (PedsQL Cancer Module) is a widely used, cancer-specific questionnaire measuring health-related quality of life (HRQoL) in children and adolescents with cancer, using both child self-report and parent proxy-report, assessing dimensions like pain, fatigue, treatment anxiety, and appearance.
|
- At the admission to the ward - At 60 days after HSCT
|
|
Changes in immunological variables
Time Frame: - At 60 days after HSCT - At 90 days after HSCT
|
Immune recovery will be evaluated through the counting of the different populations of white blood cells (leukocytes, monocytes and lymphocytes), of the lymphocyte subpopulations (total T lymphocytes (CD45+ CD3+ CD56-), B lymphocytes (CD19+ CD20+), NK lymphocytes (CD45+ CD3- CD56+), CD4+ T lymphocytes (CD3+ CD4+ CD8-) and CD8+ T lymphocytes (CD3+ CD4- CD8 +).
|
- At 60 days after HSCT - At 90 days after HSCT
|
Collaborators and Investigators
Investigators
- Principal Investigator: Francesco Saglio, PhD Medical Doctor, A.O.U. Città della Salute e della Scienza - OIRM
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GAST
- 137/2022 (Other Identifier: Comitato Etico Interaziendale AOU Città della Salute e della Scienza di Torino, AO Mauriziano e ASL Città di Torino)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oncology
-
Çanakkale Onsekiz Mart UniversityActive, not recruitingOncology | Physiology | Geriatric OncologyTurkey (Türkiye)
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
MaineHealthTufts Medical CenterRecruitingOncology | Prehabilitation | Surgical OncologyUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
University of SaskatchewanNot yet recruiting
-
Leiden University Medical CenterDutch Cancer SocietyRecruiting
-
Başakşehir Çam & Sakura City HospitalNot yet recruiting
Clinical Trials on control group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Chengdu Sport UniversityNot yet recruiting
-
Hanlim Pharm. Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
The First Affiliated Hospital of Zhejiang Chinese...Not yet recruitingAdolescent Idiopathic ScoliosisChina
-
International University of La RiojaCompletedPsychosis | Therapy | PsychologicalSpain
-
Physicians Committee for Responsible MedicineMetropolitan Police Department of Washington, D.C.SuspendedDiabetes Mellitus, Type 2 | Overweight | Blood PressureUnited States
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
Romanian Society of Anesthesia and Intensive CareUniversity of Medicine and Pharmacy "Victor Babes" Timisoara; Timişoara County...Completed